Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

INVO Fertility (IVF) Other Non Operating Income (2017 - 2025)

INVO Fertility (IVF) has disclosed Other Non Operating Income for 11 consecutive years, with -$692270.0 as the latest value for Q2 2025.

  • On a quarterly basis, Other Non Operating Income fell 1609.69% to -$692270.0 in Q2 2025 year-over-year; TTM through Jun 2025 was -$732761.0, a 259.84% decrease, with the full-year FY2024 number at -$40491.0, up 75.2% from a year prior.
  • Other Non Operating Income was -$692270.0 for Q2 2025 at INVO Fertility, down from -$40491.0 in the prior quarter.
  • In the past five years, Other Non Operating Income ranged from a high of $161339.0 in Q4 2021 to a low of -$692270.0 in Q2 2025.
  • A 5-year average of -$52884.0 and a median of -$804.5 in 2021 define the central range for Other Non Operating Income.
  • Biggest YoY gain for Other Non Operating Income was 98.41% in 2023; the steepest drop was 30003.88% in 2023.
  • INVO Fertility's Other Non Operating Income stood at $161339.0 in 2021, then plummeted by 100.34% to -$541.0 in 2022, then tumbled by 30003.88% to -$162862.0 in 2023, then surged by 75.14% to -$40491.0 in 2024, then plummeted by 1609.69% to -$692270.0 in 2025.
  • Per Business Quant, the three most recent readings for IVF's Other Non Operating Income are -$692270.0 (Q2 2025), -$40491.0 (Q2 2024), and -$162862.0 (Q4 2023).